Harmony Biosciences’ (HRMY) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report report published on Tuesday,Benzinga reports. HC Wainwright currently has a $70.00 price target on the stock. A number of other brokerages also recently commented on HRMY. Mizuho upped their target price on Harmony Biosciences from $42.00 […]
